Immunordic ApS
Private limited companyCVR 43773070København ØActive
Immunordic ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2023. The company went from a profit in 2024 to a loss of DKK 293k in 2025. Equity fell to DKK 606k in 2025. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 146% (2024 → 2025), to DKK 2.4m.
- Net profit went from a profit of DKK 7,762 to a loss of DKK 293k (2024 → 2025).
- Equity fell 33% (2024 → 2025), to DKK 606k.
Management and owners, last 24 months
- New owners registered: Arvedsen & Faliu Holding ApS (01/11/2024) and Niels Hermann Kristiansen (01/11/2024).
- No longer registered as owner: Niels Hermann Kristiansen (31/10/2024), Arvedsen & Faliu Holding ApS (31/10/2024) and Niels Hermann Kristiansen (20/05/2026).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
- 01/11/2024: Share capital changed from 42,149 DKK to 43,764 DKK
- 01/11/2024: Name changed from Synobody ApS to Immunordic ApS
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | 541 | 956 | 2,352 | +146.1% |
| Profit before tax | −78 | −23 | 82 | +458.8% |
| Net profit | −49 | 8 | −293 | −3,872.2% |
| Total assets | 1,054 | 3,606 | 5,933 | +64.6% |
| Equity | −9 | 899 | 606 | −32.6% |
| Liabilities | – | 2,286 | 4,169 | +82.3% |
| Cash and cash equivalents | 14 | 173 | 79 | −54.2% |
| Average number of employees | 2 | 3 | 5 | +66.7% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresEquity fell sharply
Equity fell 33% from 2024 to 2025 (DKK 899k to DKK 606k).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 24/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 24/06/2025 | The company | PDF not statedXBRL |
| 2023 | 12/01/2023 – 31/12/2023 | 17/06/2024 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 27,565of 69,742 Better than 60% | No. 39,907of 69,964 Better than 43% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 81of 323 Better than 75% | No. 169of 329 Better than 49% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 4,992of 16,614 Better than 70% | No. 5,252of 16,661 Better than 68% |
| All companies of type ApS66,508 companies in the comparison | No. 26,897of 66,379 Better than 59% | No. 35,808of 66,505 Better than 46% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Immunordic ApSDKK 2.4m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Immunordic ApS−DKK 293k
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Immunordic ApSDKK 606k
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Immunordic ApS5
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Arvedsen & Faliu Holding ApS100%
Management
2 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Emil Arvedsen | Director | 12/01/2023 |
| Jannik Faliu | Director | 12/01/2023 |
- Founders
- Arvedsen & Faliu Holding ApS
Signing rule: Selskabet tegnes af to direktører i forening eller af den samlede direktion.
Address and production units
1 active production unitsFruebjergvej 3
2100 København Ø
København Municipality · Postcode 2100
Other companies at the address (8)
- Vektor Ejendomme A/SBuying and selling of own real estate
- Symbion A/SRenting of commercial property
- Synopsys Denmark ApSComputer consultancy and computer facilities management
- Clinical-Microbiomics A/SResearch and experimental development on natural sciences and engineering
- River Stone Biotech ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Immunordic ApS | Fruebjergvej 3, 2100 København Ø | 5 | 1028921248 |
Purpose
Selskabets formål er direkte eller indirekte at drive bioteknologi-virksomhed, herunder forskning, eksperimentel udvikling og salg af antistoffer, herunder single-domain antistoffer, samt al virksomhed, som efter direktionens skøn har forbindelse hermed.
The purpose is quoted from the register in Danish.
Changes year by year
19 registered events20262 changesaccounts 1 · ownership 1
- AccountsAnnual report for 2025 published
- OwnershipNiels Hermann Kristiansen is no longer registered as owner
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202411 changesname 1 · capital 2 · ownership 7 · accounts 1
- NameName changed from Synobody ApS to Immunordic ApS
- CapitalShare capital changed from 42,149 DKK to 43,764 DKK
- OwnershipNiels Hermann Kristiansen registered as owner (5%)
- OwnershipArvedsen & Faliu Holding ApS registered as owner (100%)
- OwnershipNiels Hermann Kristiansen is no longer registered as owner
- OwnershipArvedsen & Faliu Holding ApS is no longer registered as owner
- AccountsAnnual report for 2023 published
- CapitalShare capital changed from 40,000 DKK to 42,149 DKK
- OwnershipNiels Hermann Kristiansen registered as owner (5%)
- OwnershipArvedsen & Faliu Holding ApS registered as owner (90%)
- OwnershipArvedsen & Faliu Holding ApS is no longer registered as owner
20234 changesfounded 1 · management 2 · ownership 1
- FoundedRegistered as Synobody ApS
- ManagementEmil Arvedsen appointed director
- ManagementJannik Faliu appointed director
- OwnershipArvedsen & Faliu Holding ApS registered as owner (100%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- Pentabase A/Svia Niels Hermann Kristiansen
- Duckling Media ApSvia Niels Hermann Kristiansen
- GlyProVac ApSvia Niels Hermann Kristiansen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.